| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Stroke. 2006;37:1123.)
© 2006 American Heart Association, Inc.
Comments, Opinions, and Reviews |
From the Department of Physiology and Pharmacology (I.S., J.C., V.J., J.H.Z.), Division of Neurosurgery (J.H.Z.), and Department of Anesthesiology (J.H.Z.), Loma Linda University School of Medicine, Loma Linda, Calif.
Correspondence to John H. Zhang, MD, PhD, Division of Neurosurgery, Loma Linda University Medical Center, 11234 Anderson St, Room 2562B, Loma Linda, CA 92354. E-mail johnzhang3910{at}yahoo.com
Background and Purpose Granulocyte-colony stimulating factor (G-CSF) is a growth factor that orchestrates the proliferation, differentiation, and survival of hematopoietic progenitor cells. It has been used for many years in clinical practice to accelerate the recovery of patients from neutropenia after cytotoxic therapy. However, there is a growing body of evidence from experimental studies suggesting that G-CSF also has important nonhematopoietic functions in the central nervous system.
Summary of Review The presence of the G-CSF/G-CSFreceptor system in the brain and its role in neuroprotection and neural tissue repair has been investigated in many recent studies. The neuroprotective actions of G-CSF have mainly been attributed to its anti-inflammatory and antiapoptotic effects. Furthermore, it induces neurogenesis and angiogenesis and improves functional recovery. In this review, we summarize the role of G-CSF and the corresponding signal transduction pathways regulated by G-CSF in neuroprotection.
Conclusions Much additional work is needed to better understand the precise mechanisms of G-CSFinduced neuroprotection. However, there is emerging data suggesting that G-CSF is a potential new agent for neuroprotection.
Key Words: granulocyte-colony stimulating factor growth factor neuroprotection stem cell stroke
This article has been cited by other articles:
![]() |
T. Matsumoto, M. Moriya, H. Kiyohara, Y. Tabuchi, and H. Yamada Hochuekkito, a Kampo (Traditional Japanese Herbal) Medicine, and its Polysaccharide Portion Stimulate G-CSF Secretion from Intestinal Epithelial Cells Evid. Based Complement. Altern. Med., February 27, 2008; (2008) nen007v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Anderlini and R. E. Champlin Biologic and molecular effects of granulocyte colony-stimulating factor in healthy individuals: recent findings and current challenges Blood, February 15, 2008; 111(4): 1767 - 1772. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Weng, A. P. Signore, Y. Gao, S. Wang, F. Zhang, T. Hastings, X.-M. Yin, and J. Chen Leptin Protects against 6-Hydroxydopamine-induced Dopaminergic Cell Death via Mitogen-activated Protein Kinase Signaling J. Biol. Chem., November 23, 2007; 282(47): 34479 - 34491. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Dziennis, T. Jia, O. K. Ronnekleiv, P. D. Hurn, and N. J. Alkayed Role of Signal Transducer and Activator of Transcription-3 in Estradiol-Mediated Neuroprotection J. Neurosci., July 4, 2007; 27(27): 7268 - 7274. [Abstract] [Full Text] [PDF] |
||||
![]() |
W.-R. Schabitz and A. Schneider Developing Granulocyte-Colony Stimulating Factor for the Treatment of Stroke: Current Status of Clinical Trials Stroke, July 1, 2006; 37(7): 1654 - 1654. [Full Text] [PDF] |
||||
![]() |
I. Solaroglu, J. Cahill, V. Jadhav, and J. H. Zhang Response to Letter by Schabitz et al Stroke, July 1, 2006; 37(7): 1655 - 1655. [Full Text] [PDF] |
||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2006 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |